Bioengineered Let-7c Inhibits Orthotopic Hepatocellular Carcinoma and Improves Overall Survival with Minimal Immunogenicity

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths, warranting better therapies. Restoration of tumor-suppressive microRNAs depleted in hepatocellular carcinoma represents a new therapeutic strategy. Herein, we sought to identify a potent microRNA (miRNA) agent that coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Jilek, Joseph L., Zhang, Qian-Yu, Tu, Mei-Juan, Ho, Pui Yan, Duan, Zhijian, Qiu, Jing-Xin, Yu, Ai-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370598/
https://www.ncbi.nlm.nih.gov/pubmed/30753993
http://dx.doi.org/10.1016/j.omtn.2019.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370598/
https://www.ncbi.nlm.nih.gov/pubmed/30753993
http://dx.doi.org/10.1016/j.omtn.2019.01.007

Ejemplares similares